WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.74 Billion CNY | -2.02% |
| 2022 | 5.86 Billion CNY | 36.94% |
| 2021 | 4.28 Billion CNY | -0.22% |
| 2020 | 4.29 Billion CNY | -24.6% |
| 2019 | 5.69 Billion CNY | 390.56% |
| 2018 | 1.16 Billion CNY | -29.01% |
| 2017 | 1.63 Billion CNY | 234.13% |
| 2016 | 489.38 Million CNY | 184.53% |
| 2015 | 172 Million CNY | -84.91% |
| 2014 | 1.13 Billion CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 7.09 Billion CNY | 23.43% |
| 2024 Q3 | 5.61 Billion CNY | -4.85% |
| 2024 Q2 | 7.16 Billion CNY | 1.01% |
| 2023 Q2 | 5.68 Billion CNY | -0.84% |
| 2023 Q1 | 5.72 Billion CNY | -2.34% |
| 2023 FY | 5.74 Billion CNY | -2.02% |
| 2023 Q4 | 5.74 Billion CNY | -8.19% |
| 2023 Q3 | 6.26 Billion CNY | 10.21% |
| 2022 Q3 | 5.48 Billion CNY | 11.21% |
| 2022 Q1 | 4.77 Billion CNY | 11.57% |
| 2022 FY | 5.86 Billion CNY | 36.94% |
| 2022 Q4 | 5.86 Billion CNY | 6.92% |
| 2022 Q2 | 4.93 Billion CNY | 3.22% |
| 2021 Q4 | 4.28 Billion CNY | -0.81% |
| 2021 FY | 4.28 Billion CNY | -0.22% |
| 2021 Q1 | 4.07 Billion CNY | -5.07% |
| 2021 Q2 | 4.44 Billion CNY | 9.03% |
| 2021 Q3 | 4.31 Billion CNY | -2.8% |
| 2020 Q4 | 4.29 Billion CNY | -8.61% |
| 2020 Q3 | 4.69 Billion CNY | -14.75% |
| 2020 Q2 | 5.51 Billion CNY | -9.16% |
| 2020 Q1 | 6.06 Billion CNY | 6.54% |
| 2020 FY | 4.29 Billion CNY | -24.6% |
| 2019 Q3 | 4.94 Billion CNY | 129.87% |
| 2019 FY | 5.69 Billion CNY | 390.56% |
| 2019 Q4 | 5.69 Billion CNY | 15.1% |
| 2019 Q2 | 2.15 Billion CNY | 82.6% |
| 2019 Q1 | 1.17 Billion CNY | 1.54% |
| 2018 Q4 | 1.16 Billion CNY | -45.91% |
| 2018 FY | 1.16 Billion CNY | -29.01% |
| 2018 Q3 | 2.14 Billion CNY | 8.07% |
| 2018 Q2 | 1.98 Billion CNY | 7.22% |
| 2018 Q1 | 1.85 Billion CNY | 13.28% |
| 2017 FY | 1.63 Billion CNY | 234.13% |
| 2017 Q3 | 1.38 Billion CNY | 0.0% |
| 2017 Q4 | 1.63 Billion CNY | 18.22% |
| 2017 Q1 | 607.16 Million CNY | 0.0% |
| 2016 FY | 489.38 Million CNY | 184.53% |
| 2015 FY | 172 Million CNY | -84.91% |
| 2014 FY | 1.13 Billion CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -256492.227% |
| Arrayit Corporation | 1.07 Million USD | -532996.068% |
| Atlantic International Corp. | 2.93 Million USD | -196033.472% |
| Biocept, Inc. | 12.1 Million USD | -47366.066% |
| Bioqual, Inc. | 3.58 Million USD | -160136.686% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -7915268.783% |
| DermTech, Inc. | 54.39 Million USD | -10466.728% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | -1118.065% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -118802.104% |
| iMD Companies, Inc. | 1.12 Million USD | -513016.192% |
| IDenta Corp. | 789.14 Thousand USD | -728239.989% |
| Interpace Biosciences, Inc. | 11.19 Million USD | -51255.128% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -13108956.65% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -71344.715% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -150130.819% |
| NovelStem International Corp. | 3.57 Million USD | -160691.907% |
| Optigenex Inc. | 8.94 Million USD | -64186.272% |
| PharmChem, Inc. | 77.35 Thousand USD | -7430336.942% |
| Proteome Sciences plc | 17.15 Million USD | -33406.907% |
| Response Genetics, Inc | 6.37 Million USD | -90087.759% |
| Rennova Health, Inc. | 15.32 Million USD | -37394.525% |
| RushNet, Inc. | 4.82 Million USD | -119069.536% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -2776094.194% |
| Stella Diagnostics Inc. | 6.2 Million USD | -92594.047% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -319200.048% |
| Todos Medical Ltd. | 38.34 Million USD | -14888.176% |